Melatonin administration after pilocarpine-induced status epilepticus: A new way to prevent or attenuate postlesion epilepsy?

Epilepsy and Behavior

Volumn 20, Issue 4, 2011, Pages 607-612

  Lima, Eliângela ^a   Cabral, Francisco R ^a,b   Cavalheiro, Esper A ^a   Naffah Mazzacoratti, Maria da Graça ^a   Amado, Débora ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

Author keywords

Epilepsy; Experimental model; Melatonin; N acetylserotonin; Neuroprotection; Pilocarpine; Status epilepticus

Indexed keywords

MELATONIN; N ACETYLSEROTONIN; PILOCARPINE; SODIUM CHLORIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; EPILEPTIC STATE; HISTOPATHOLOGY; MALE; NONHUMAN; PARAMETER; RAT;

ANALYSIS OF VARIANCE; ANIMALS; ANTIOXIDANTS; CELL DEATH; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; MALE; MELATONIN; PILOCARPINE; RATS; RATS, WISTAR; SEROTONIN; STATISTICS AS TOPIC; STATUS EPILEPTICUS;

EID: 79954590097     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2011.01.018     Document Type: Article

References (38)

1. Brzezinski A. Melatonin in humans. N Engl J Med 1997, 336:186-195.
2. Reiter R.J., Melchiorri D., Sewerynek E., et al. A review of the evidence supporting melatonin's role as an antioxidant. J Pineal Res 1995, 18:1-11.
3. Reiter R.J. Oxidative damage in the central nervous system: protection by melatonin. Prog Neurobiol 1998, 56:359-384.
4. Lotufo C.M., Lopes C., Dubocovich M.L., Farsky S.H., Markus R.P. Melatonin and N-acetylserotonin inhibit leukocyte rolling and adhesion to rat microcirculation. Eur J Pharmacol 2001, 430:351-357.
5. Acunã-Castroviejo D., Escames G., Macías M., et al. Cell protective role of melatonin in the brain. J Pineal Res 1995, 19:57-63.
6. Siu A.W., Reiter R.J., To C.H. Pineal indoleamines and vitamin E reduce nitric oxide-induced lipid peroxidation in rat retinal homogenates. J Pineal Res 1999, 27:122-128.
7. Bachurin S., Oxenkrug G., Lermontova Afanasiev A., et al. N-Acetyl-serotonin, melatonin and their derivatives improve cognition and protect against β-amyloid-induced neurotoxicity. Ann NY Acad Sci 1999, 890:155-166.
8. Leone R.M., Silman R.E. Melatonin can be differentially metabolized in the rat to produce N-acetyl-serotonin in addition to 6-hydroxy-melatonin. Endocrinology 1984, 114:1825-1832.
9. Young I.M., Leone R.M., Frabcis P., Stovell P., Silman R.E. Melatonin is metabolized to N-acetyl-serotonin and 6-hydroxy-melatonin in man. J Clin Endocrinol Metab 1985, 60:114-119.
10. Oxenkrug G., Requintina P., Bachurin S. Antioxidant and antiaging activity of N-acetylserotonin in vivo models. Ann NY Acad Sci 2001, 939:190-199.
11. Strine T.W., Kobau R., Chapman D.P., Thurman D.J., Price P., Balluz L.S. Psychological distress, comorbities, and health behaviors among U.S. adults with seizures: results from the 2002 National Health Interview Survey. Epilepsia 2005, 46:1133-1139.
12. Fisher R.S., van Emde Boas W., Blume W., et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy. Epilepsia 2005, 46:470-472.
13. Peled N., Shorer Z., Peled E., Pillar G. Melatonin's effect on seizures in children with severe neurologic deficit disorders. Epilepsia 2001, 42:1208-1210.
14. Gupta M., Aneja S., Kohli K. Add-on melatonin improves quality of life in epileptic children on valproate monotherapy: a randomized, double-blind, placebo-controlled trial. Epilepsy Behav 2004, 5:316-321.
15. Bazil C.W., Short D., Crispin D., Zheng W. Patients with intractable epilepsy have low melatonin, which increases following seizures. Neurology 2000, 55:1746-1748.
16. Yehuda S., Mostofsky D.I. Circadian effects of beta-endorphin, melatonin, DSIP, and amphetamine on pentylenetetrazol-induced seizures. Peptides 1993, 14:203-205.
17. Lapin I.P., Mirzaev S.M., Rysov I.V., Oxenkrug G.F. Anticonvulsant activity of melatonin against seizures induced by quinolinate, kainate, glutamate, NMDA, and pentylenetetrazole in mice. J Pineal Res 1998, 24:215-218.
18. Yamamoto H., Tang H. Melatonin attenuates L-cysteine-induced seizures and lipid peroxidation in the brain of mice. J Pineal Res 1996, 21:108-113.
19. Albertson T.E., Peterson S.L., Stark L.G., Lakin M.L., Winters W.D. The anticonvulsant properties of melatonin on kindled seizures in rats. Neuropharmacology 1981, 20:61-66.
20. Mevissen M., Ebert U. Anticonvulsant effects of melatonin in amygdala-kindled rats. Neurosci Lett 1998, 257:13-16.
21. Uz T., Giusti P., Franceschini D., Kharlamov A., Manev H. Protective effect of melatonin against hippocampal DNA damage induced by intraperitoneal administration of kainate to rats. Neuroscience 1996, 73:631-636.
22. Wu F.S., Yang Y.C., Tsai J.J. Melatonin potentiates the GABAA receptor-mediated current in cultured chick spinal cord neurons. Neurosci Lett 1999, 260:177-180.
23. Engel J.Jr. Mesial temporal lobe epilepsy: what have we learned?. Neuroscientist 2001, 7(4):340-352.
24. McKeown M.J., McNamara J.O. When do epileptic seizures really begin?. Neuron 2001, 30:1-3.
25. Lima E., Soares J.M., Garrido Y.C.S., et al. Effects of pinealectomy and the treatment with melatonin on the temporal lobe epilepsy in rats. Brain Res 2005, 1043:24-31.
26. Racine R.J. Modification of seizure activity by electrical stimulation: II. Motor seizure. Electroencephalogr Clin Neurophysiol 1972, 32:281-294.
27. Janjoppi L., Lacerda A.F.S., Scorza F.A., Amado D., Cavalheiro E.A., Arida R.M. Influence of pinealectomy on the amygdala kindling development of rats. Neurosci Lett 2006, 392:150-153.
28. VanLandingham K.E., Heinz E.R., Cavazos J.E., Lewis D.V. Magnetic resonance imaging evidence of hippocampal injury after prolonged focal febrile convulsions. Ann Neurol 1998, 43:413-426.
29. Provenzale J.M., Barboriak D.P., VanLandingham K., MacFall J., Delong D., Lewis D.V. AJR Am J Roentgenol 2008, 190:976-983.
30. Sloviter R.S. On the relationship between neuropathology and pathophysiology in the epileptic hippocampus of humans and experimental animals. Hippocampus 1994, 4:250-253.
31. Sloviter R.S. Experimental status epilepticus in animals: what are we modeling?. Epilepsia 2009, 50(Suppl. 12):11-13.
32. Lima E., Cabral F.R., Perosa S.R., Cavalheiro E.A., Naffah-Mazzacoratti M.G., Amado D. Could melatonin treatment during pilocarpine-induced status epilepticus prevent or attenuate postlesion epilepsy?. Journal of Pineal Research 2011.
33. Council for International Organizations of Medical Services (CIOMS/OMS) International guiding principles for biomedical research involving animals 1985, WHO Distribution and Sales Service, Geneva.
34. Cavazos J.E., Golarai G., Sutula T.P. Mossy fiber synaptic reorganization induced by kindling: time course of development, progression, and permanence. J Neurosci 1991, 11:2795-2803.
35. Sudgen D.J. Psychopharmacological effects of melatonin in mouse and rats. Pharmacol Exp Ther 1983, 227:587-591.
36. Borowicz K.K., Kaminski R., Gasior M., Kleinrok Z., Czuczwar S.J. Influence of melatonin upon the protective action of conventional anti-epileptic drugs against maximal electroshock in mice. Neuropharmacology 1999, 9:185-190.
37. Chung S.Y., Han S.H. Melatonin attenuates kainic-induced hippocampal neurodegeneration and oxidative stress through microglial inhibition. J Pineal Res 2003, 34:95-102.
38. Mikaellof Y., Jambaqué I., Hertz-Pannier L., et al. Devastating epileptic encephalopathy in school-aged children (DESC): a pseudo encephalitis. Epilepsy Res 2006, 69:67-79.